KIR3DL1 and stroke disorder: Licensing process of NKs and T cells may probably help to explain different effects of KIR and HLA repertoire in different subtype of strokes but future studies addressed to analyze these differences in larger sample of subjects with acute ischemic stroke may contribute to add further advances about this issue.